Body weight and blood pressure changes on dolutegravir‐, efavirenz‐ or atazanavir‐based antiretroviral therapy in Zimbabwe: a longitudinal study

Abstract Introduction Dolutegravir (DTG) is widely used for antiretroviral therapy (ART). We compared weight and blood pressure trends and examined the association between high blood pressure and weight gain among people living with HIV (PLHIV) switching to or starting DTG‐based, efavirenz (EFV)‐bas...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Tinei Shamu, Matthias Egger, Tinashe Mudzviti, Cleophas Chimbetete, Justen Manasa, Nanina Anderegg
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2024-02-01
Saila:	Journal of the International AIDS Society
Gaiak:	HIV dolutegravir blood pressure hypertension body weight Zimbabwe
Sarrera elektronikoa:	https://doi.org/10.1002/jia2.26216
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!